FGFR1 and neoplasm: AZD4547 is a highly selective and potent ATP-competitive TKI of FGFR1–3 and inhibited recombinant FGFR kinase activity in vitro and suppressed FGFR signaling and growth in tumor cell lines with deregulated FGFR expression [47].